Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The study was a randomized, open label, two-treatment, two-period, two-sequence, single dose,
crossover, oral bioequivalence study in normal, healthy adult human subjects under fed
condition.